4 June 2020 Media Release
Results International (Australia), a global health advocacy organisation, applauds world leaders for significant new financial commitments to Gavi, the Vaccine Alliance. This will help deliver 3 billion doses of life-saving vaccines to 300 million children in some of the world’s poorest countries. Since its inception in 2000, Gavi has helped to save lives, reduce poverty and protect the world against the threat of epidemics.
Today, the Australian Government pledged $300 million to Gavi which will help create equal access to vaccines for children throughout the world.
‘We congratulate the Australian government for this announcement, and for its strategically-important leadership on this vital issue,’ said Negaya Chorley, RESULTS’ CEO. ‘At a time of unprecedented demands on our national finances, Australia has stepped up with funding that matches our long-term commitment to immunisation.’
Gavi has also committed to making any future COVID-19 vaccine available in low-income countries. ‘Once a vaccine for COVID-19 is available, it is key the poorest as well as the wealthiest countries are able to access it,’ Ms Chorley continued. ‘The current pandemic has underlined the fact that infectious diseases respect no borders. Health systems in all countries will need to be at their strongest in order to deliver the COVID-19 vaccine as widely as possible, to both adults and children.’
Australia’s commitment will be announced tonight (Australian time) at Gavi’s Global Vaccine Summit, hosted by the UK government. It will be among pledges expected from more than 25 Heads of State and the private sector.
‘Over the next five years, Gavi plans to immunise 140 million children in the Indo-Pacific, this will play a key role in ending poverty in our region.’ Ms Chorley concluded.
Media inquiries: Michelle Imison Phone: 0412 045 132
RESULTS International (Australia) is an advocacy organisation working to influence policy and mobilise resources to fight diseases of poverty and achieve equitable access to health.